APA (7th ed.) Citation

Gong, W., Wang, L., Schubert, M., Kleist, C., Neuber, B., Wang, S., . . . Sellner, L. (2022). HDAC inhibition for optimized cellular immunotherapy of NY-ESO-1-positive soft tissue sarcoma. Biomedicines, 10(2), . https://doi.org/10.3390/biomedicines10020373

Chicago Style (17th ed.) Citation

Gong, Wenjie, et al. "HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-positive Soft Tissue Sarcoma." Biomedicines 10, no. 2 (2022). https://doi.org/10.3390/biomedicines10020373.

MLA (9th ed.) Citation

Gong, Wenjie, et al. "HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-positive Soft Tissue Sarcoma." Biomedicines, vol. 10, no. 2, 2022, https://doi.org/10.3390/biomedicines10020373.